Case number 1:17-cv-00675
Bayer Intellectual Property GmbH et al v. Alembic Pharmaceuticals Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 30, 2020 | 28 | Order (2) |
| Dec 30, 2020 | 28 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218. (Attachments: # (1) Order)(nms) |
| Dec 22, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. 230 in Lead Civil Action 17-462-TBD. (nms) |
| Dec 21, 2020 | 27 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding closure of underlying cases. (Blumenfeld, Jack) |
| Dec 21, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties shall file a status letter within 7 days of the date of this Order. Ordered by Judge Richard G. Andrews on 12/21/2020. (nms) |
| Jul 8, 2020 | 1 | Complaint (12) |
| Feb 8, 2019 | 25 | Order Administratively Closing Case (1) Docket Text: ORDER Administratively Closing Case (see Order for further details). Signed by Judge Richard G. Andrews on 2/7/2019. (nms) |
| Nov 13, 2017 | 24 | Order (7) Docket Text: SO ORDERED Granting (26 in 17-cv-1163-RGA, 28 in 17-cv-462-RGA, 27 in 17-cv-584-RGA, 23 in 17-cv-675-RGA, 29 in 17-cv-648-RGA, 24 in 17-cv-560-RGA, 29 in 17-cv-1129-RGA, 26 in 17-cv-483-RGA, 25 in 17-cv-812-RGA, 32 in 17-cv-1047-RGA) Stipulation and Order of Consolidation. Signed by Judge Richard G. Andrews on 11/13/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Nov 10, 2017 | 23 | Stipulation (7) Docket Text: STIPULATION and [Proposed] Order of Consolidation by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Nov 10, 2017 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Pharmaceuticals Limited, Alembic Global Holding SA, and Alembic Pharmaceuticals, Inc.'s Core Technical Documents filed by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Farnan, Kelly) |
| Oct 24, 2017 | 21 | Order (30) Docket Text: SO ORDERED Granting Stipulated Protective Order. Signed by Judge Richard G. Andrews on 10/24/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Oct 23, 2017 | 20 | Proposed Order (30) Docket Text: PROPOSED Protective Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/23/2017 (nms). |
| Oct 23, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (25 in 17-cv-462-RGA, 19 in 17-cv-675-RGA, 27 in 17-cv-1047-RGA, 26 in 17-cv-648-RGA, 23 in 17-cv-1163-RGA, 22 in 17-cv-483-RGA, 22 in 17-cv-812-RGA, 24 in 17-cv-1129-RGA, 21 in 17-cv-560-RGA, 23 in 17-cv-584-RGA) Stipulation and Order on Proposed Protective Order. Signed by Judge Richard G. Andrews on 10/23/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Oct 20, 2017 | 19 | Stipulation (6) Docket Text: STIPULATION and Order on Proposed Protective Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/23/2017 (nms). |
| Oct 17, 2017 | N/A | SO ORDERED (0) |
| Oct 16, 2017 | 18 | Motion for Leave to Appear Pro Hac Vice (13) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Todd L. Krause of Sidley Austin LLP - filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 13, 2017 | 17 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of (1) Bayer Intellectual Property GmbH and Bayer AG's Initial Disclosures; and (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Oct 13, 2017 | 16 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures of Defendants Alembic Pharmaceuticals Limited, Alembic Global Holding SA, and Alembic Pharmaceuticals, Inc. filed by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Farnan, Kelly) |
| Oct 11, 2017 | 15 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of Plaintiffs Bayer Intellectual Property GmbH, Bayer AG, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Oct 10, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Teresa M. Summers for Alembic Global Holding SA,Teresa M. Summers for Alembic Pharmaceuticals Limited,Teresa M. Summers for Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Oct 6, 2017 | N/A | SO ORDERED (0) |
| Oct 5, 2017 | 14 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Teresa M. Summers of Wiley Rein LLP - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Farnan, Kelly) |
| Oct 2, 2017 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00462-RGA et al.(cak) |
| Oct 2, 2017 | 13 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/9/2018. Amended Pleadings due by 3/9/2018. Fact Discovery completed by 8/10/2018. Joint Claim Construction Brief due by 6/22/2018. A Markman Hearing is set for 7/3/2018, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 3/22/2019, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A 3 day Bench Trial is set for 4/1/2019, at 9:30 AM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/29/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Sep 29, 2017 | 12 | Letter (1) |
| Sep 29, 2017 | 12 | Main Document (11) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Smith, Rodger) Modified on 9/29/2017 (nms). |
| Sep 29, 2017 | 12 | Proposed Order (11) |
| Sep 11, 2017 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 9/11/2017. (Court Reporter Valerie Gunning.) Associated Cases: 1:17-cv-00462-RGA et al.(ksr, ) |
| Sep 8, 2017 | 11 | Motion for Leave to Appear Pro Hac Vice (16) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Adam L. Perlman, Dov P. Grossman, Alexander S. Zolan, Martha C. Kidd and Kathryn S. Kayali - filed by Bayer AG, Bayer Intellectual Property GmbH. (Smith, Rodger) |
| Sep 8, 2017 | N/A | SO ORDERED (0) |
| Sep 7, 2017 | 10 | Proposed Order (11) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/7/2017 (nms). |
| Sep 1, 2017 | 9 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 9/11/2017, at 11:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/1/2017. (nms) |
| Aug 11, 2017 | 8 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alembic Pharmaceuticals, Ltd. for Alembic Global Holding SA; Corporate Parent Alembic Global Holding SA for Alembic Pharmaceuticals, Inc. filed by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Farnan, Kelly) |
| Aug 11, 2017 | 7 | Answer to Complaint (12) Docket Text: ANSWER to [1] Complaint, and Affirmative Defenses, by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc..(Farnan, Kelly) Modified on 8/16/2017 (nms). |
| Jun 7, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jun 2, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alembic Global Holding SA on 6/5/2017; Alembic Pharmaceuticals Limited on 6/5/2017; Alembic Pharmaceuticals, Inc. on 6/5/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Jun 2, 2017 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (nmg) |
| Jun 2, 2017 | 1 | Main Document (12) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2154890.) - filed by Bayer Intellectual Property GmbH, Bayer AG, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg) |
| Jun 2, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GmbH filed by Bayer AG, Bayer Intellectual Property GmbH. (nmg) |
| Jun 2, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218. (nmg) |
| Jun 2, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/24/2017. Date of Expiration of Patent: 2/17/2034.Thirty Month Stay Deadline: 10/24/2019. (nmg) |
| Jun 2, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jun 2, 2017 | 1 | Civil Cover Sheet (1) |
| Jun 2, 2017 | 1 | Exhibit A (14) |
| Jun 2, 2017 | 1 | Complaint* (1) |
